Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Hideharu Harada"'
Publikováno v:
Hepatology Research. 33:211-215
Thrombocytopenia is frequently found in patients with chronic liver disease, and associated with advanced fibrosis stage and with decreased liver function. Serum thrombopoietin (TPO) levels also decrease as the disease progresses from mild fibrosis t
Autor:
Hiroaki Okamoto, Akihisa Tanaka, Hiroshi Kamitsukasa, Fukui H, Hideharu Harada, Hajime Tokita, Michiyasu Yagura
Publikováno v:
Journal of Gastroenterology and Hepatology. 20:752-758
Background and Aim: Hepatitis C virus (HCV)-infected patients who responded to interferon (IFN) treatment with clearance of serum HCV RNA may rarely develop hepatocellular carcinoma (HCC). The aim of the present study was to elucidate the risk factor
Autor:
Michiyasu Yagura, Hajime Tokita, Akira Ohbayashi, Hideo Tanaka, Hiroshi Kamitsukasa, Hideharu Harada
Publikováno v:
Hepatology. 41:819-825
Although several cohort studies have been reported in individuals with chronic hepatitis C virus (HCV) infection, little is known about liver-related mortality among the elderly. We conducted a cohort study in 302 patients with tuberculosis sequelae
Publikováno v:
Kanzo. 46:19-25
結婚後50年経ってHCVの夫婦間感染が成立した1例を報告した. 妻は72歳. 1955年出産時に輸血. 1989年に初めて肝機能異常を指摘され, 1992年より当院へ通院. 1992年4月, 肝生検はF1/A1, HCV-RNA8.7Meq/ml.
Autor:
Hideharu Harada, Hiroshi Kamitsukasa, Hiroaki Okamoto, Masaharu Takahashi, Seiyou Murai, Hajime Tokita, Michiyasu Yagura
Publikováno v:
Journal of Medical Virology. 67:501-509
The TT virus (TTV) load was estimated in sera obtained from 237 patients with hepatitis C virus (HCV)-related chronic liver disease including 42 patients with hepatocellular carcinoma (HCC), by real-time detection PCR using primers and a probe derive
Autor:
Hideharu Harada, Hajime Tokita, Seiyou Murai, Michiyasu Yagura, Hiroshi Kamitsukasa, Akira Hebisawa, Hiroaki Okamoto, Masaharu Takahashi
Publikováno v:
Hepatology Research. 19:197-211
The sera of 38 patients with nonalcoholic fatty liver disease (NAFLD) including nonalcoholic steatohepatitis (NASH), were tested for TT virus (TTV) DNA by polymerase chain reaction (PCR) using three different primer pairs (UTR PCR, N22 PCR and genoty
Autor:
Akio Tawara, Hajime Tokita, Masaharu Takahashi, Hiroaki Okamoto, Hideharu Harada, Seiyou Murai, Hiroshi Kamitsukasa, Michiyasu Yagura
Publikováno v:
Hepatology Research. 19:180-193
The sera of 43 patients with alcoholic liver disease (ALD) who abstained from alcohol for 4 weeks, were tested for TT virus (TTV) DNA by polymerase chain reaction (PCR) using three different primer pairs (UTR PCR, N22 PCR and genotype-1 PCR). The cli
Autor:
Michio Imawari, Hiromitsu Kumada, Namiki Izumi, Mikio Zeniya, Naoaki Hashimoto, Hideharu Harada, Gotaro Toda
Publikováno v:
Digestive Diseases and Sciences. 46:516-523
Virological response to interferon (IFN) is poor in patients with plasma levels of HCV RNA higher than 1 Meq/ml and genotype 1b hepatitis C viral infection. In 60 patients, a randomized control study was conducted to compare 3 MU of IFN-β twice dail
Autor:
Michiyasu Yagura, Hajime Tokita, Hideharu Harada, Seiyou Murai, Hiroshi Kojima, Hiroshi Kamitsukasa
Publikováno v:
Journal of Gastroenterology. 35:105-111
The aim of this study was to evaluate the antifibrotic effect of interferon (IFN)-alpha in chronic hepatitis C (CH-C) patients with no response to IFN-alpha therapy. We studied 76 patients (46 men, 30 women; mean age, 55.6 years) who received IFN-alp
Publikováno v:
Hepatology Research. 14:18-25
We investigated the parameters predicting the response to ursodeoxycholic acid (UDCA) therapy in chronic hepatitis C patients. A total of 62 patients, with histologically proven chronic hepatitis C and elevated serum alanin aminotransferase (ALT) lev